New Zealand markets closed

Hoth Therapeutics, Inc. (HOTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8260+0.0445 (+5.69%)
At close: 04:00PM EDT
0.8300 +0.00 (+0.48%)
After hours: 07:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.70M
Enterprise value -3.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.61
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.40

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-40.14%
S&P500 52-week change 332.65%
52-week high 31.7300
52-week low 30.5800
50-day moving average 30.8150
200-day moving average 31.1116

Share statistics

Avg vol (3-month) 33.72M
Avg vol (10-day) 3130.75k
Shares outstanding 56.9M
Implied shares outstanding 66.9M
Float 86.84M
% held by insiders 10.93%
% held by institutions 15.05%
Shares short (13 Sept 2024) 4245.29k
Short ratio (13 Sept 2024) 40.03
Short % of float (13 Sept 2024) 43.57%
Short % of shares outstanding (13 Sept 2024) 43.55%
Shares short (prior month 15 Aug 2024) 4212.46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:25
Last split date 326 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-42.66%
Return on equity (ttm)-77.36%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.46M
Diluted EPS (ttm)-1.5500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.65M
Total cash per share (mrq)1.4
Total debt (mrq)41.1k
Total debt/equity (mrq)0.44%
Current ratio (mrq)14.62
Book value per share (mrq)1.74

Cash flow statement

Operating cash flow (ttm)-8.02M
Levered free cash flow (ttm)-5.02M